Addressing molecular targets, that are overexpressed by various tumor entities, using
radiolabeled molecules for a combined diagnostic and therapeutic (theranostic) approach is …

Introduction Prostate and breast cancer represent a leading cause of cancer-related death
worldwide with a dramatic social and demographic impact. Gastrin-releasing peptide …

Prostate cancer is a critical public health problem in USA and Europe. New non-invasive
imaging methods are urgently needed, due to the low accuracy and specificity of current …

The gastrin‐releasing peptide receptor (GRPR) is overexpressed in prostate cancer and
other solid malignancies. Following up on our work on [68Ga] Ga‐ProBOMB1 that had better …

Simple Summary Prostate and breast cancers are the most common malignancies. Accurate
diagnosis and staging of diseases are important for the prognosis and determination of …

Gastrin-releasing peptide receptors (GRPRs), part of the bombesin (BBN) family, are
aberrantly overexpressed in many cancers, including those of the breast, prostate, pancreas …

Prostate cancer is one of the most common causes of cancer in men. Evaluating the different
stages of prostate cancer with conventional imaging techniques still proves difficult. Nuclear …

The gastrin-releasing peptide receptor (GRPR) is overexpressed in many solid
malignancies, particularly in prostate and breast cancers, among others. We synthesized …

Simple Summary Recent medical advancements have strived for a personalized medicine
approach to patients, aimed at optimizing therapy outcomes with minimum toxicity. In this …

The rare-earth radionuclides that decay by beta particle (β-&) emission are considered to be
ideal in the context of targeted radiotherapy. The rare-earth isotopes exist primarily in the 3+ …